Join Andrei Georgescu (VivoDyne CEO), Serafim Batzoglou (Seer Chief Data Officer), Dave Longo (Ordaōs CEO), Alex Zhavoronkov (Insilico Medicine Founder), and Young Kwon (Alchemab Therapeutics PhD) as they revolutionize drug R&D. Discover how VivoDyne's bioengineering platform is transforming tissue sample research. Learn about Seer's nanoparticle technologies that unveil more proteins than ever. Uncover Ordaōs' innovative mini-proteins reshaping drug development and the impact of AI on discovering therapies for complex diseases. It's a deep dive into the future of medicine!